496 related articles for article (PubMed ID: 22652772)
1. The Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis.
Lau AW; Fukushima H; Wei W
Front Biosci (Landmark Ed); 2012 Jun; 17(6):2197-212. PubMed ID: 22652772
[TBL] [Abstract][Full Text] [Related]
2. Involvement of F-BOX proteins in progression and development of human malignancies.
Uddin S; Bhat AA; Krishnankutty R; Mir F; Kulinski M; Mohammad RM
Semin Cancer Biol; 2016 Feb; 36():18-32. PubMed ID: 26410033
[TBL] [Abstract][Full Text] [Related]
3. Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer.
Xie CM; Wei W; Sun Y
J Genet Genomics; 2013 Mar; 40(3):97-106. PubMed ID: 23522382
[TBL] [Abstract][Full Text] [Related]
4. DNA damage-induced activation of ATM promotes β-TRCP-mediated Mdm2 ubiquitination and destruction.
Wang Z; Inuzuka H; Zhong J; Fukushima H; Wan L; Liu P; Wei W
Oncotarget; 2012 Sep; 3(9):1026-35. PubMed ID: 22976441
[TBL] [Abstract][Full Text] [Related]
5. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction.
Inuzuka H; Shaik S; Onoyama I; Gao D; Tseng A; Maser RS; Zhai B; Wan L; Gutierrez A; Lau AW; Xiao Y; Christie AL; Aster J; Settleman J; Gygi SP; Kung AL; Look T; Nakayama KI; DePinho RA; Wei W
Nature; 2011 Mar; 471(7336):104-9. PubMed ID: 21368833
[TBL] [Abstract][Full Text] [Related]
6. Physiological Functions of FBW7 in Metabolism.
Zhang J; Kong DH; Huang X; Yu R; Yang Y
Horm Metab Res; 2022 May; 54(5):280-287. PubMed ID: 35533672
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitylation of the amino terminus of Myc by SCF(β-TrCP) antagonizes SCF(Fbw7)-mediated turnover.
Popov N; Schülein C; Jaenicke LA; Eilers M
Nat Cell Biol; 2010 Oct; 12(10):973-81. PubMed ID: 20852628
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin-specific protease USP47 is a novel beta-TRCP interactor regulating cell survival.
Peschiaroli A; Skaar JR; Pagano M; Melino G
Oncogene; 2010 Mar; 29(9):1384-93. PubMed ID: 19966869
[TBL] [Abstract][Full Text] [Related]
9. Regulating Fbw7 on the road to cancer.
Xu W; Taranets L; Popov N
Semin Cancer Biol; 2016 Feb; 36():62-70. PubMed ID: 26459133
[TBL] [Abstract][Full Text] [Related]
10. The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis.
Biswas M; Phan D; Watanabe M; Chan JY
J Biol Chem; 2011 Nov; 286(45):39282-9. PubMed ID: 21953459
[TBL] [Abstract][Full Text] [Related]
11. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
[TBL] [Abstract][Full Text] [Related]
12. MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation.
Galli F; Rossi M; D'Alessandra Y; De Simone M; Lopardo T; Haupt Y; Alsheich-Bartok O; Anzi S; Shaulian E; Calabrò V; La Mantia G; Guerrini L
J Cell Sci; 2010 Jul; 123(Pt 14):2423-33. PubMed ID: 20571051
[TBL] [Abstract][Full Text] [Related]
13. Stringent Control of NFE2L3 (Nuclear Factor, Erythroid 2-Like 3; NRF3) Protein Degradation by FBW7 (F-box/WD Repeat-containing Protein 7) and Glycogen Synthase Kinase 3 (GSK3).
Kannan MB; Dodard-Friedman I; Blank V
J Biol Chem; 2015 Oct; 290(43):26292-302. PubMed ID: 26306035
[TBL] [Abstract][Full Text] [Related]
14. F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor.
Sancho R; Jandke A; Davis H; Diefenbacher ME; Tomlinson I; Behrens A
Gastroenterology; 2010 Sep; 139(3):929-41. PubMed ID: 20638938
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus E1A inhibits SCF(Fbw7) ubiquitin ligase.
Isobe T; Hattori T; Kitagawa K; Uchida C; Kotake Y; Kosugi I; Oda T; Kitagawa M
J Biol Chem; 2009 Oct; 284(41):27766-27779. PubMed ID: 19679664
[TBL] [Abstract][Full Text] [Related]
16. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.
Welcker M; Orian A; Jin J; Grim JE; Harper JW; Eisenman RN; Clurman BE
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9085-90. PubMed ID: 15150404
[TBL] [Abstract][Full Text] [Related]
17. ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer.
Ji S; Qin Y; Shi S; Liu X; Hu H; Zhou H; Gao J; Zhang B; Xu W; Liu J; Liang D; Liu L; Liu C; Long J; Zhou H; Chiao PJ; Xu J; Ni Q; Gao D; Yu X
Cell Res; 2015 May; 25(5):561-73. PubMed ID: 25753158
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1-F-box interface.
Gorelik M; Orlicky S; Sartori MA; Tang X; Marcon E; Kurinov I; Greenblatt JF; Tyers M; Moffat J; Sicheri F; Sidhu SS
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3527-32. PubMed ID: 26976582
[TBL] [Abstract][Full Text] [Related]
19. The characteristics and roles of β-TrCP1/2 in carcinogenesis.
Bi Y; Cui D; Xiong X; Zhao Y
FEBS J; 2021 Jun; 288(11):3351-3374. PubMed ID: 33021036
[TBL] [Abstract][Full Text] [Related]
20. Mcl-1 ubiquitination and destruction.
Inuzuka H; Fukushima H; Shaik S; Liu P; Lau AW; Wei W
Oncotarget; 2011 Mar; 2(3):239-44. PubMed ID: 21608150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
